EHA25

Hemostasis Today

NewsFeed Voices Science Insight Innovation

June, 2025

EHA25

Jun 18, 2025, 10:50 | Organizations

EHA 2025 Was a Great Success - VJHemOnc

The Video Journal of Hematology & Hematological Oncology (VJHemOnc) shared a post on X: "EHA…

Jun 17, 2025, 17:07 | Voices

Mark Wildgust: Outstanding Results from the FLAIR Study Presented at EHA25

Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson…

Jun 16, 2025, 18:24 | Science

Talha Badar: TKI Selection Based on Mutation Profiles in CML at EHA 2025

Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X: "Emergence of ASXL1…

Jun 16, 2025, 15:00 | Voices

Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA 2025

Thomas Miller, Principal Investigator at Institut Paoli-Calmettes, shared a post on LinkedIn: "Unlocking Smarter BCL-2…

Jun 16, 2025, 02:06 | Insight

C. Ola Landgren: Presenting ADVANCE Trial Results in Multiple Myeloma at EHA25

C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center,…

Jun 16, 2025, 02:02 | Voices

Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health…

All: 6 Posts: 1 - 100

'

ASH Recognizes 11 Hematologists for Transformative Contributions to Blood Disorder Research

'

25 Posts Not to Miss from EHA 2025

'

Methamphetamine Abuse Triggers Severe Thrombotic Microangiopathy

'

The ISTH proudly presents the Harold R. Roberts Award to Dr. Robert R. Montgomery

'

3-Year Outcomes of AAV Gene Therapy in Hemophilia B: Study Published in NEJM Shows Long-Term Factor IX Expression